Rongxi Yang

5.7k total citations
55 papers, 1.8k citations indexed

About

Rongxi Yang is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rongxi Yang has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rongxi Yang's work include Epigenetics and DNA Methylation (38 papers), RNA modifications and cancer (14 papers) and Cancer-related gene regulation (13 papers). Rongxi Yang is often cited by papers focused on Epigenetics and DNA Methylation (38 papers), RNA modifications and cancer (14 papers) and Cancer-related gene regulation (13 papers). Rongxi Yang collaborates with scholars based in China, Germany and United States. Rongxi Yang's co-authors include Barbara Burwinkel, Hermann Brenner, Lutz Philipp Breitling, Bernhard Korn, Katarina Ćuk, Dharanija Madhavan, Gang Pei, Christof Sohn, Bin Qu and Andreas Schneeweiß and has published in prestigious journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Rongxi Yang

48 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongxi Yang China 15 1.5k 587 209 158 148 55 1.8k
Jung H. Kim United States 18 1.7k 1.1× 827 1.4× 183 0.9× 199 1.3× 240 1.6× 40 2.3k
Pavlo Lutsik Germany 21 1.2k 0.8× 243 0.4× 367 1.8× 151 1.0× 133 0.9× 44 1.7k
Giang Huong Nguyen United States 22 1.4k 1.0× 813 1.4× 248 1.2× 372 2.4× 159 1.1× 48 2.3k
Yanhua Gong China 22 1.1k 0.7× 607 1.0× 73 0.3× 160 1.0× 83 0.6× 66 1.6k
Yiqin Wang China 23 994 0.7× 386 0.7× 136 0.7× 157 1.0× 99 0.7× 73 1.6k
Dongjun Dai China 20 1.0k 0.7× 600 1.0× 104 0.5× 208 1.3× 117 0.8× 60 1.5k
Bekim Sadiković Canada 30 1.8k 1.2× 731 1.2× 813 3.9× 240 1.5× 283 1.9× 130 2.7k
Felicitas Lacbawan United States 21 931 0.6× 292 0.5× 565 2.7× 101 0.6× 90 0.6× 50 1.8k
Alicia Rivera United States 21 707 0.5× 293 0.5× 135 0.6× 214 1.4× 288 1.9× 61 1.7k
David Delano United States 8 1.2k 0.8× 198 0.3× 433 2.1× 87 0.6× 119 0.8× 9 1.8k

Countries citing papers authored by Rongxi Yang

Since Specialization
Citations

This map shows the geographic impact of Rongxi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongxi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongxi Yang more than expected).

Fields of papers citing papers by Rongxi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongxi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongxi Yang. The network helps show where Rongxi Yang may publish in the future.

Co-authorship network of co-authors of Rongxi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Rongxi Yang. A scholar is included among the top collaborators of Rongxi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongxi Yang. Rongxi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiao, Rong, Wenli Li, Runbo Zhong, et al.. (2025). The association between blood-based HYAL2 methylation and early-stage lung cancer: a case-control study. PubMed. 14(1). 2477411–2477411.
2.
3.
Li, Junjie, Yifei Yin, Mengxia Li, et al.. (2023). RUNX1 Methylation as a Cancer Biomarker in Differentiating Papillary Thyroid Cancer from Benign Thyroid Nodules. Epigenomics. 15(23). 1257–1272. 2 indexed citations
4.
Zhao, Xiaojing, Chao Zhu, Mengxia Li, et al.. (2023). Hypomethylation of ABCG1 in peripheral blood as a potential marker for the detection of coronary heart disease. Clinical Epigenetics. 15(1). 120–120. 3 indexed citations
5.
Li, Lixi, Jiaqi Li, Yunhui Qu, et al.. (2023). The association between CTSZ methylation in peripheral blood and breast cancer in Chinese women. Frontiers in Oncology. 13. 1148635–1148635. 5 indexed citations
6.
Zhu, Liya, et al.. (2023). Identification of an association between coronary heart disease and ITGB2 methylation in peripheral blood by a case-control study. Clinica Chimica Acta. 552. 117627–117627. 3 indexed citations
7.
Zhu, Chao, et al.. (2022). The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population. BMC Cardiovascular Disorders. 22(1). 370–370. 2 indexed citations
8.
Zhao, Xiaojing, et al.. (2022). F2RL3 Methylation in the Peripheral Blood as a Potential Marker for the Detection of Coronary Heart Disease: A Case-Control Study. Frontiers in Genetics. 13. 833923–833923. 9 indexed citations
9.
Qiao, Rong, Xu Tian, Liping Dai, et al.. (2022). The influence of blood sample processing on blood-based DNA methylation signatures. Clinical Biochemistry. 115. 116–125. 2 indexed citations
10.
Liu, Chunlan, et al.. (2021). ACTB Methylation in Blood as a Potential Marker for the Pre-clinical Detection of Stroke: A Prospective Nested Case-Control Study. Frontiers in Neuroscience. 15. 644943–644943. 11 indexed citations
11.
Qiao, Rong, Runbo Zhong, Chunlan Liu, et al.. (2021). Novel blood-based hypomethylation of SH3BP5 is associated with very early-stage lung adenocarcinoma. Genes & Genomics. 44(4). 445–453. 8 indexed citations
12.
Qiao, Rong, Jun Wang, Yujie Wei, et al.. (2020). <p>The Association Between RAPSN Methylation in Peripheral Blood and Early Stage Lung Cancer Detected in Case–Control Cohort</p>. Cancer Management and Research. Volume 12. 11063–11075. 13 indexed citations
13.
Yang, Xiaoqin, Lixi Li, Xu Tian, et al.. (2020). The Association Between Breast Cancer and Blood-Based Methylation of S100P and HYAL2 in the Chinese Population. Frontiers in Genetics. 11. 977–977. 12 indexed citations
14.
Yang, Hongmei, et al.. (2016). Synergism between PGC-1&alpha; and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Pfütze, Katrin, Axel Benner, Michael Hoffmeister, et al.. (2015). Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy. Genomics. 106(6). 348–354. 18 indexed citations
16.
Yang, Rongxi, et al.. (2013). F2RL3 Methylation as a Biomarker of Current and Lifetime Smoking Exposures. Environmental Health Perspectives. 122(2). 131–137. 93 indexed citations
17.
Madhavan, Dharanija, Katarina Ćuk, Barbara Burwinkel, & Rongxi Yang. (2013). Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. Frontiers in Genetics. 4. 116–116. 120 indexed citations
18.
Madhavan, Dharanija, Manuela Zucknick, Markus Wallwiener, et al.. (2012). Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer. Clinical Cancer Research. 18(21). 5972–5982. 214 indexed citations
19.
Breitling, Lutz Philipp, Rongxi Yang, Bernhard Korn, Barbara Burwinkel, & Hermann Brenner. (2011). Tobacco-Smoking-Related Differential DNA Methylation: 27K Discovery and Replication. The American Journal of Human Genetics. 88(4). 450–457. 487 indexed citations
20.
Kang, Jiuhong, Yufeng Shi, Bin Xiang, et al.. (2006). A Nuclear Function of β-Arrestin1 in GPCR Signaling: Regulation of Histone Acetylation and Gene Transcription. Cell. 124(3). 645–645. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jung H. Kim Breakdown of academic impact, for papers by Pavlo Lutsik Breakdown of academic impact, for papers by Giang Huong Nguyen Breakdown of academic impact, for papers by Yanhua Gong Breakdown of academic impact, for papers by Yiqin Wang Breakdown of academic impact, for papers by Dongjun Dai Breakdown of academic impact, for papers by Bekim Sadiković Breakdown of academic impact, for papers by Felicitas Lacbawan Breakdown of academic impact, for papers by Alicia Rivera Breakdown of academic impact, for papers by David Delano
Rankless by CCL
2026